SEARCH RESULTS FOR:

Romain Trapp

PRESIDENT AND CEO, AIRBUS HELICOPTERS CANADA
Ontario Aerospace 2017
Fort Erie in Ontario is an important and expanding hub for Airbus Helicopters and Canada is a top market.

Brian Reilly

MANAGING DIRECTOR, CAMECO
Western Australia Mining 2017 Pre-Release
With vast economically recoverable uranium resources yet a newly elected government, the future of uranium mining in WA remains uncertain.

Chris Molloy

SENIOR VICE PRESIDENT, OFFICE OF RESEARCH AND ECONOMIC DEVELOPMENT, RUTGERS UNIVERSITY
United States Biopharmaceuticals 2017
Rutgers University is a leading national research university that works alongside its corporate neighbors to foster developments in the health sector.

Debbie Hart

PRESIDENT AND CEO, BIONJ
United States Biopharmaceuticals 2017
BioNJ is involved in ensuring that New Jersey retains its leading position as a center of global life sciences by facilitating the industry’s development.

Paying the Price: U.S. Biopharma Industry

United States Biopharmaceuticals 2017
Slashing drug prices might benefit patients in the short term, but at what cost?

John McConnell

PRESIDENT & CEO, VICTORIA GOLD CORPORATION
British Columbia, Yukon and Vancouver Mining 2017
Victoria Gold is leading the revival of interest in Yukon and aims to begin production at its Eagle Gold project in 2018.

Reg Howard-Smith

CHIEF EXECUTIVE, THE CHAMBER OF MINERALS AND ENERGY OF WESTERN AUSTRALIA (CME)
Western Australia Mining 2017 Pre-Release
The CME takes a stance against the National Party’s mining tax proposal.

George Bauk

MANAGING DIRECTOR AND CEO, NORTHERN MINERALS
Western Australia Mining 2017 Pre-Release
Navigating sustainable energy with dysprosium, the element needed for permanent magnets.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.

PARTNER EVENTS